Focus: PulseMedica is a public-stage biotechnology company headquartered in Edmonton, AB, focused on vitreoretinal screening and ophthalmology solutions. The company operates with minimal publicly available financial data and a very small active hiring footprint (3 open roles).
Profile data last refreshed 12h ago · AI intelligence enriched 3w ago
Stable — net -3 jobs in 30d
0 added, 3 removed. Backfill posture.
PulseMedica is a high-risk, early-stage opportunity best suited for ophthalmology specialists willing to accept ambiguous development timelines and minimal hiring velocity in exchange for potential ground-floor equity upside.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for PulseMedica
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from PulseMedica's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles